Functional Test for a Drink Powder Alone and Combined Use With a Cosmetic Apparatus
NCT ID: NCT05041205
Last Updated: 2021-09-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2021-05-22
2021-08-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Collagen Efficacy on Skin Anti-aging in 30 to 50-Year-Old Women
NCT05682092
12-Week Study on the Efficacy of Two Serums in Improving Skin Aging and Tone
NCT07156071
Lotion and Toner Bundle 4-Week Lifting Efficacy Study
NCT07127653
Evaluation of Soy Isoflavones on Skin Ageing Parameters
NCT06047145
A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming
NCT04065035
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Clinical assessment is performed by expert visual grading on
* Skin evenness
* Skin radiance
* Skin elasticity
* Skin smoothness
* Skin firmness
* Skin moisture
* Skin plumpness
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo control group
placebo drink powder without active ingredients, 1 sachet per day with 50 ml water for 12 weeks
Beauty drink powder
Beauty drink powder is designed as a oral beauty product to provide benefits to skin
Beauty drink powder group
Beauty drink powder is the test article provide to participants, 1 sachet per day with 50 ml water for 12 weeks
Beauty drink powder
Beauty drink powder is designed as a oral beauty product to provide benefits to skin
cosmetic apparatus group
This group is designed for a cosmetic apparatus control group without consumption of placebo or test article. Together with the specified cleanser, the apparatus is used for daily facial cleaning, two times in the morning and evening for 12 weeks.
Cosmetic apparatus
This device is designed to let participants to experience brighter, softer, smoother skin and an energizing facial massage. A synergestic effect when combine with beauty drink powder is expected.
Beauty drink powder + cosmetic apparatus group
In this group, Beauty drink powder is consumed 1 sachet daily with 50 ml water and the cosmetic apparatus is used together with the specified cleanser for daily facial cleaning, two times in the morning and evening for 12 weeks.
Beauty drink powder
Beauty drink powder is designed as a oral beauty product to provide benefits to skin
Cosmetic apparatus
This device is designed to let participants to experience brighter, softer, smoother skin and an energizing facial massage. A synergestic effect when combine with beauty drink powder is expected.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Beauty drink powder
Beauty drink powder is designed as a oral beauty product to provide benefits to skin
Cosmetic apparatus
This device is designed to let participants to experience brighter, softer, smoother skin and an energizing facial massage. A synergestic effect when combine with beauty drink powder is expected.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects with skin problems such as skin dullness, skin tone unevenness, skin inelasticity, skin dryness, and wrinkle/fine lines.
* Subjects without any other chronic or on treatment diseases
* Subjects are voluntary to participate the trial and signed informed consents.
* Subjects are voluntary to follow all evaluation criteria
Exclusion Criteria
* Not participated any clinical trial or evaluation within nearly 1 month;
* Used anti-histamine medication within nearly one week or immunosuppressor within nearly one month
* Used any anti-inflammation drugs at test site within nearly two months
* Subjects who have any skin diseases (psoriasis, eczema, skin cancer etc.)
* Subjects with Type I diabetes
* Subjects who currently are receiving asthma or other chronic respiratory diseases treatment
* Subjects who are receiving anti-cancer chemotherapy in nearly 6 months
* Subjects who have anyother health problem or chronic diseases
* Subjects who have externally used Vit A, a-hydroxy acid, salicylic acid, hydroquinone within nearly 3 months or prescription medicines, oral contraceptive within nearly 6 months
* Expert or professional person evaluate have other iatrogenic reason may impact the evaluation results
30 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pharmanex
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wenwen Gu, PhD
Role: PRINCIPAL_INVESTIGATOR
Shanghai China-norm Quality Technical Service Co., Ltd.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai China-norm Quality Technical Service Co., Ltd.
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C210201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.